Target intelligence / Profile preview

Solute carrier family 13 member 4 (SLC13A4)

Target
SLC13A4
Molecular classification
Transporter, Membrane protein, Sodium:sulfate symporter, Solute carrier family protein (SLC family)
01

Overview

Solute carrier family 13 member 4 (SLC13A4) is a membrane-bound sodium:sulfate symporter that mediates sodium-dependent sulfate reabsorption across cell membranes, especially in high endothelial venules and the placenta. The protein spans the membrane 12 times and is essential for sulfate uptake critical for fetal development and skeletal formation. Loss of function in mice causes severe developmental defects and embryonic lethality. SLC13A4 is closely related to other SLC13 family members (such as SLC13A1), but is distinguished by its tissue distribution and specific physiological roles in sulfate homeostasis and developmental processes. Its activity can be inhibited by certain inorganic anions and it is implicated in rare developmental and skeletal disorders in humans. No drug targeting SLC13A4 is currently approved, but its biochemical and physiological features make it a potential target for modulation in diseases that involve sulfate transport dysfunction.

Other names
Sodium/sulfate cotransporter SUT-1SUT1NaS2Sulphate transporter 1NAS2
02

Mechanism of action

Inhibitors block the sulfate symporter's transport function by competing for the same binding site or altering transporter conformation

03

Biological functions

Sulfate transportSodium-dependent anion transportTransmembrane transportRegulation of sulfate homeostasisFetal development (especially placental sulfate reabsorption)Skeletal development
04

Disease associations

Developmental defects (placental sulfate transport deficiency, embryonic lethality in animal models)Chondrodysplasia with joint dislocations, GPAPP typeDevelopmental and epileptic encephalopathy 25 with amelogenesis imperfecta
05

Safety considerations

Developmental risks in fetal disorders due to transporter deficiencyPossible systemic sulfate imbalance if pharmacologically targeted or genetically disrupted
06

Interacting drugs

thiosulfate

4 more in the full profile.

07

Biomarkers

Potential use as a biomarker for placental sulfate transport function or developmental disorders, but no established clinical biomarkers for monitoring patient response or selection

Beyond the preview

Go deeper on Solute carrier family 13 member 4 (SLC13A4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 13 member 4 (SLC13A4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call